Utilization of innovative medical technologies in German inpatient care: does evidence matter?

BACKGROUND: The reimbursement of new technologies in inpatient care is not always linked to a requirement for evidence-based evaluation of patient benefit. In Germany, every new technology approved for market was until recently eligible for reimbursement in inpatient care unless explicitly excluded....

Descripción completa

Detalles Bibliográficos
Autores principales: Eckhardt, Helene, Felgner, Susanne, Dreger, Marie, Fuchs, Sabine, Ermann, Hanna, Rödiger, Hendrikje, Rombey, Tanja, Busse, Reinhard, Henschke, Cornelia, Panteli, Dimitra
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10546629/
https://www.ncbi.nlm.nih.gov/pubmed/37784100
http://dx.doi.org/10.1186/s12961-023-01047-w

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10546629/
https://www.ncbi.nlm.nih.gov/pubmed/37784100
http://dx.doi.org/10.1186/s12961-023-01047-w

Ejemplares similares